chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: PNC15
Symptoms: Injury associated with device, Skin laceration, Syringe issue
Clinical narrative: syringe broke just below the luer lock hub; HCP reported that broken glass lacerated her thumb.; HCP reported that broken glass lacerated her thumb.; This spontaneous report was received from a registered nurse and refers to a non pregnant female patient. There was no information about patient's concomitant medications, concurrent conditions or pertinent medical history.  On 14-JUL-2023, the patient was vaccinated with a dose of pneumococcal 15v conj vaccine (crm197)(VAXNEUVANCE) 0.5 milliliter, lot number W039033, expiration date reported as 10-OCT-2024 but upon internal validation was established as 01-OCT-2024 (dose, route and anatomical location were not reported) for prophylaxis.  On the same date, while attaching needle to syringe, syringe broke just below the luer lock hub (Syringe issue). The reporter stated that the broken glass lacerated her thumb (Skin laceration, injury associated with device). The patient sought medical attention, the laceration was irrigated and bandaged by the health care professional.  At the time of the report, the patient was recovering from the skin laceration.  The relatedness between the event of skin laceration and therapy with pneumococcal 15v conj vaccine (crm197)(VAXNEUVANCE) was not reported.
Sex: U
Vaccine: MMRV
Symptoms: No adverse event, Product storage error
Clinical narrative: No additional AE; PROQUAD that was administered to a patient following TE; This spontaneous report was received from a nurse referring to a patient of unknown age and gender. The patient's pertinent medical history, drug reactions/allergies, concurrent conditions and concomitant medications were not reported.      On 29-JUL-2023, the patient was vaccinated with improperly stored measles, mumps, rubella and varicella (oka-merck) virus vaccine live(PROQUAD) 0.5ml dose, albumin status rHA lot # W032150 with expiration date 07-APR-2024, for prophylaxis (strength, route of administration and anatomical location were not reported). No symptoms and no additional adverse event (AE) were reported. The vaccine was exposed to a temperature of 14.1 °F / 14°F up to 46°F for 2 hours. There were not prior temperature excursions.
Age: 6.0
Sex: U
Vaccine: MMRV
Symptoms: No adverse event, Product storage error
Clinical narrative: No adverse effects reported.; TE with PROQUAD from 8/19/2022. Administered to this patient on 9/26/2022; This spontaneous report has been received from an unspecified reporter, reporting to a 7-year-old patient of unknown gender. Information regarding medical history, concurrent conditions and concomitant medication was not provided.  On 26-SEP-2022, the patient was vaccinated with incorrect store dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live rHA (PROQUAD) injection, lot # U039261, expiration date 09-JUN-2023, 0.5 milliliter for prophylaxis (route of administration not reported). No adverse effects reported.  This is one of several cases from the same reporter.; Sender's Comments:  US-009507513-2308USA000495:02439769 US-009507513-2308USA000450:02439770 US-009507513-2308USA000144:02439771 US-009507513-2308USA000432:02439807 US-009507513-2308USA000185:02439808 US-009507513-2308USA000637:02439801 US-009507513-2308USA000669:02439777
Age: 17.0
Sex: U
Vaccine: MMRV, VARCEL
Symptoms: Incorrect dose administered, Product administered to patient of inappropriate age
Clinical narrative: the patient inadvertently received both  VARIVAX and PROQUAD in the same day.; also notes that the patient is above 12 years of age (17 years old); No symptomatic AE reported; This spontaneous report has been received from a registered nurse and refers to a 17-year-old patient of unknown gender. The patient's pertinent medical history, concurrent conditions, concomitant medications, and drug reactions or allergies were not provided.  On 01-NOV-2022, the patient was vaccinated with measles, mumps, rubella and varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) injection, 0.5 milliliter (ml) and with varicella virus vaccine live (Oka/Merck) (VARIVAX) injection 0.5 ml (dose number, frequency, route of administration vaccination scheme, anatomical location lot number and expiration date were not provided for both vaccines), administered for prophylaxis, on the same date (accidental overdose). Additionally, the patient was above 12 years of age (product administered to patient of inappropriate age).  No symptomatic adverse event (AE) reported.
Age: 59.0
Sex: F
Vaccine: TDAP
Symptoms: Incorrect route of product administration
Clinical narrative: Wrong Route of Administration; This non-serious case was reported by a nurse via call center representative and described the occurrence of intramuscular formulation administered by other route in a 59-year-old female patient who received DTPa (Reduced antigen) (Boostrix) (batch number 2B723, expiry date 17-OCT-2025) for prophylaxis.   On 26-JUL-2023, the patient received Boostrix (subcutaneous). On 26-JUL-2023, an unknown time after receiving Boostrix, the patient experienced intramuscular formulation administered by other route (Verbatim: Wrong Route of Administration). The outcome of the intramuscular formulation administered by other route was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK receipt date: 31-Jul-2023 The nurse manager stated that the patient received Boostrix via subcutaneously instead of intramuscularly, which led to Intramuscular formulation administered by other route. The vaccine administration facility was the same as primary reporter. The reporter consented to follow up via postal.
Age: 74.0
Sex: M
Vaccine: HEPAB
Symptoms: Inappropriate schedule of product administration
Clinical narrative: received their second dose of Twinrix 2 months after the initial dose; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of drug dose administration interval too long in a 74-year-old male patient who received HAB (Twinrix) for prophylaxis.   Concomitant products included HEPATITIS A VACCINE + HEPATITIS B VACCINE (TWINRIX).   On 31-JUL-2023, the patient received the 2nd dose of Twinrix. On 31-JUL-2023, an unknown time after receiving Twinrix, the patient experienced drug dose administration interval too long (Verbatim: received their second dose of Twinrix 2 months after the initial dose). The outcome of the drug dose administration interval too long was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK receipt date: 31-Jul-2023 The reporter provided limited information about the vaccine, patient and event. The patient received 2nd dose of Twinrix 2 months after the initial dose, which led to lengthening of vaccination schedule. The vaccine administration facility was same as the primary reporter. The reporter consented to follow up.
Sex: U
Vaccine: COVID19
Symptoms: Pericarditis
Clinical narrative: Pericarditis; This literature-non-study case was reported in a literature article and describes the occurrence of PERICARDITIS (Pericarditis) in a  patient of an unknown age and gender who received mRNA-1273 (Spikevax) for COVID-19 prophylaxis.   No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced PERICARDITIS (Pericarditis) (seriousness criterion medically significant). At the time of the report, PERICARDITIS (Pericarditis) had resolved.        For mRNA-1273 (Spikevax) (Unknown), the reporter considered PERICARDITIS (Pericarditis) to be related.    This case was for patient no.5, who experienced pericarditis after second dose of Moderna vaccine.  No concomitant or treatment medications were reported.  This study is based on a cohort evaluation of all adults administered =1 mRNA COVID-19 vaccine, including boosters, in the Agency between 14 December 2020 and 9 October 2022.  From 14 December 2020 to 9 October 2022, 2 184 449 first and 2 036 948 second doses of mRNA-1273 (Moderna) were administered. In addition, 1 156 160 mRNA-1273 booster doses were administered. Among vaccine recipients in our cohort aged 1839 (predominately male, as expected in a cohort), estimated incidence rates of confirmed myocarditis/pericarditis ranged from 0.46 cases per million (for Moderna dose 1, all ages) to 19.76 (Pfizer dose 2, ages 1839). Of the 178 potential safety events identified by the RCA, only 33 were ultimately confirmed following an mRNA vaccine. Potential cases were ruled out after chart review for various reasons. In summary, the incidence of myocarditis or pericarditis in patients was low across >10 million doses of mRNA COVID-19 vaccines (primary or booster doses) administered.   This case was linked to US-MODERNATX, INC.-MOD-2023-734758 (Linked Report).  Company Comment: This is a literature non-study case concerning a patient of unknown age and gender, with no reported medical history, who experienced the serious (due to medically significant) expected, event of Pericarditis, which occurred after the second dose of mRNA-1273 vaccine. Temporal association cannot be assessed due to lack of information on onset date of the event and vaccination date. The outcome was reported as recovered. No further clinical information was available for medical review. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.   Most recent FOLLOW-UP information incorporated above includes: On 27-Jul-2023: Live follow-up received by safety on 27-JUL-2023 has email with full text article that contains significant information: Reporter information, literature information and an updated narrative.; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-734758:Same literature (Master case)
Sex: M
Vaccine: COVID19
Symptoms: Pulmonary fibrosis
Clinical narrative: pulmonary fibrosis resulting in death; This is a spontaneous report received from a non-contactable reporter(s) (Pharmacist).  An elderly male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 20Sep2022 at 10:00 as dose 5 (booster), single (Lot number: GJ2524) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. No covid prior vaccination. Vaccination history included: Covid-19 vaccine (Primary immunization completed, manufacturer unknown ), for COVID-19 IMMUNIZATION; Covid-19 vaccine (DOSE 3 (BOOSTER), Unknown Manufacturer), for COVID-19 IMMUNIZATION; Covid-19 vaccine (DOSE 4 (BOOSTER), Unknown Manufacturer), for COVID-19 IMMUNIZATION. The following information was reported: PULMONARY FIBROSIS (death, hospitalization) with onset Oct2022, outcome "fatal", described as "pulmonary fibrosis resulting in death". The event "pulmonary fibrosis resulting in death" required emergency room visit. The patient date of death was Oct2022. Reported cause of death: "pulmonary fibrosis resulting in death". It was not reported if an autopsy was performed. No follow-up attempts are possible. No further information is expected.; Sender's Comments: Based on the limited information provided in this case, a contributory role of the suspect product BNT162b2 (COMIRNATY) to the reported event of Pulmonary Fibrosis cannot be excluded. There is very limited information provided in this report. Case will be reassessed upon receipt of additional information.; Reported Cause(s) of Death: pulmonary fibrosis resulting in death
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Drug ineffective, SARS-CoV-2 test
Clinical narrative: COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter (Physician). The reporter is the patient.  A 71-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 14Jun2023 as DOSE NUMBER UNKNOWN, SINGLE (batch/lot number: unknown) at the age of 71 years, administered in the left arm for COVID-19 immunization. The patient's relevant medical history included: "Known allergies: shrimp" (unspecified if ongoing). Other medical history was reported as "healthy." The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Jul2023, outcome "unknown" and all described as "COVID 19 Treatment." The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (Jul2023) Positive, notes: COVID 19 Treatment. Therapeutic measures were taken as a result of Drug Ineffective, Covid-19.  The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Bell's palsy, Eye disorder
Clinical narrative: Got Bells Palsy 2 days later  with many side effects    still have side effects on eye
Sex: F
Vaccine: COVID19
Symptoms: Death
Clinical narrative: DEATH; This spontaneous report received from a consumer via social media concerned a female of unspecified age, race and ethnicity. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, batch number and expiry date were not reported) dose, start therapy date were not reported, 1 total administered for covid-19 prophylaxis. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported.  On an unspecified date, the patient died from unknown cause of death. It was unspecified if an autopsy was performed. It was reported as "Your vaccine killed my mother". The action taken with covid-19 vaccine ad26.cov2.s was not applicable. This report was serious (Death).; Sender's Comments: V0: 20230764359- Death. Insufficient information is available to make a causality assessment. Therefore, this event is considered unclassifiable.; Reported Cause(s) of Death: UNKNOWN CAUSE OF DEATH
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Caesarean section, Maternal exposure before pregnancy, Oropharyngeal pain, Pregnancy
Clinical narrative: Arrived with vaginal bleeding, 36w5d gestation. Tested positive for COVID which may have precipitated PROM. Reports sore throat x4 days. Delivered by Csection. No target treatment required for COVID infection. Discharged home on POD2.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Vaginal haemorrhage
Clinical narrative: Arrived with vaginal bleeding, 36w5d gestation. Tested positive for COVID which may have precipitated PROM. Reports sore throat x4 days. Delivered by Csection. No target treatment required for COVID infection. Discharged home on POD2.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Anticoagulant therapy, COVID-19, Neurological symptom, Respiratory failure
Clinical narrative: Admit for COVID with respiratory failure. Fully vaccinated. Given O2, steroids, remdesivir, lovenox, vit-c, zinc. Developed stroke-like symtpoms during stay and was given tKN. Able to wean to 1L NC and was discharged on HHC.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, COVID-19 pneumonia, Malaise, SARS-CoV-2 test positive
Clinical narrative: Positive test several days PTA and arrived with worsening sypmtoms. Admit for COVID pna. Fully vaccinated. Placed on O2, steroids, singulair, zinc. Was able to wean to room air and discharge home.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Asthma, COVID-19, Condition aggravated, Dyspnoea, Hypoxia
Clinical narrative: Tested positive during ER visit for asthma exacerbation 3 days PTA but pt unaware of result; was dc home with oral steroid and Zpack. Presented with SOB and hypoxia, dx with COVID w/ asthma exac. Vaccinated 6/2021 but no booster yet. O2, steroids, nebs, vit-c, zince, vit-D. Able to wean to RA and was discharged home.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Tested positive during ER visit for asthma exacerbation 3 days PTA but pt unaware of result; was dc home with oral steroid and Zpack. Presented with SOB and hypoxia, dx with COVID w/ asthma exac. Vaccinated 6/2021 but no booster yet. O2, steroids, nebs, vit-c, zince, vit-D. Able to wean to RA and was discharged home.
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Anticoagulant therapy, COVID-19, Cardiac arrest, Death, Fall
Clinical narrative: Arrived to ED after fall and loss of consciousness at home. Right sided PE and pna found, all of this 2/2 COVID which was dx after admit. Rocephin/azithro, steroids, O2, zinc, heparin gtt. Deteriorated rapidly 1/21 and suffered cardiac arrest. Pt expired likely 2/2 massive PE and GIB resulting from COVID infection.
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Gastrointestinal haemorrhage, General physical health deterioration, Loss of consciousness, Pneumonia
Clinical narrative: Arrived to ED after fall and loss of consciousness at home. Right sided PE and pna found, all of this 2/2 COVID which was dx after admit. Rocephin/azithro, steroids, O2, zinc, heparin gtt. Deteriorated rapidly 1/21 and suffered cardiac arrest. Pt expired likely 2/2 massive PE and GIB resulting from COVID infection.
Age: 44.0
Sex: M
Vaccine: COVID19
Symptoms: Anticoagulant therapy, COVID-19, Diabetes mellitus, Diabetic ketoacidosis
Clinical narrative: Admit for COVID and DKA, new onset DM. Given O2, steroids, lovenox, singulair, zinc, remdesivir. Weaned to RA and discharged home
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cough, Hypoxia
Clinical narrative: Arrived with cough and hypoxia, dx with COVID. Placed on steroids, O2, nebs, vit-c, zinc. Weaned to 2L NC and discharged home on O2.
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Hypoxia
Clinical narrative: HYPOXIA
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Gastritis, Gastrointestinal disorder, Ileus, SARS-CoV-2 test positive
Clinical narrative: Arrived with GI symptoms, tested positive for COVID. Fully vaccinated. Ileus vs gastritis likely 2/2 COVID infection, no respiratory symptoms. Discharged home.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Hypotension
Clinical narrative: HYPOTENSION
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Gastrointestinal disorder, Irritable bowel syndrome
Clinical narrative: Admitted for GI symptoms in setting of IBS-D. Dx with COVID infection and GI symptoms "likely worse with COVID". No specific therapy for COVID as no respiratory symptoms. Discharged home.
Age: 47.0
Sex: F
Vaccine: VARCEL
Symptoms: Hypoaesthesia, Injection site erythema, Injection site hypoaesthesia, Injection site pruritus, Injection site swelling
Clinical narrative: Patient stated that she had a small circular red spot at the site of injection that continued to progress and get larger. It itches intermittently. It swelled up and got numb. Injection was on the right arm (subcutaneously), but patient states that her left arm kept going numb.
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, COVID-19, Malaise, Pneumonia
Clinical narrative: Presented w/COVID-like symptoms; admitted for COVID-19 infection, pna, acute resp failure; tx w/abx, O2, remdesivir, steroids, zinc; weaned to RA for dc home.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, COVID-19, Fall, SARS-CoV-2 test positive
Clinical narrative: Pt s/p right total knee arthroplasty December 20, 2021; presented to ED s/p fall from bedside with increased right knee pain. Son was COVID+ and incidental finding of COVID+ in patient but asymptomatic.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Headache, Hypotension, SARS-CoV-2 test positive
Clinical narrative: Presented to ED w c/o headache and low BP; incidental finding of COVID+, asymptomatic
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19 pneumonia, Dyspnoea, Hypoxia, Productive cough, Respiratory distress
Clinical narrative: Presented w/ respiratory distress , shortness of breath and productive cough; found to be hypoxic requiring oxygen by nasal cannula; tested positive for COVID-19 w/ left basilar pneumonia. Tx w/ O2 and steroids; weaned to RA, discharged home.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Presented w/ respiratory distress , shortness of breath and productive cough; found to be hypoxic requiring oxygen by nasal cannula; tested positive for COVID-19 w/ left basilar pneumonia. Tx w/ O2 and steroids; weaned to RA, discharged home.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, Chronic respiratory failure, Hypoxia, Respiratory failure, Sleep apnoea syndrome
Clinical narrative: SLEEP APNEA ACUTE RESPIRATORY FAILURE ACUTE HYPOXEMIC RESPIRATORY FAILURE CHRONIC HYPERCAPNIC RESPIRATORY FAILURE HYPOXIA
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Angiogram pulmonary normal, Asthenia, COVID-19, SARS-CoV-2 test positive
Clinical narrative: Presented w/ generalized weakness; found to be COVID positive, not hypoxic.  CTA chest showed no evidence of PE or pneumonia.  Patient was treated w/supportive care of Vit C & zinc.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Caesarean section, SARS-CoV-2 test positive
Clinical narrative: Admitted for labor & LTCS; incidental finding of COVID+, asymptomatic
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Encounter for lap cholecystectomy; incidental finding of COVID+ on preprocedure swab; asymptomatic
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Partial seizures
Clinical narrative: FOCAL MOTOR SEIZURE
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, COVID-19, Nausea, Pancreatitis acute, Vomiting
Clinical narrative: Presented w c/o abdominal pain, n&v; admitted for acute pancreatitits; incidental COVID-19 finding but asymptomatic
Age: 43.0
Sex: F
Vaccine: PNC20
Symptoms: Hyperhidrosis, Mobility decreased, Nausea, Pain in extremity
Clinical narrative: Sever arm pain with limited mobility. Headache, profuse sweating, and nausea.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Delivery, Labour induction, SARS-CoV-2 test positive
Clinical narrative: Presented for induction of labor and underwent uncomplicated SVD; incidental finding of COVID+, asymptomatic
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Back pain, COVID-19, Diarrhoea, Fall
Clinical narrative: Presented w c/o generalized weakness, diarrhea, status post fall with back pain; incidental finding of COVID-19+ but asymptomatic
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Presented w c/o generalized weakness, diarrhea, status post fall with back pain; incidental finding of COVID-19+ but asymptomatic
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, COVID-19 pneumonia, Dyspnoea
Clinical narrative: Presented w c/o shortness of breath and weakness.  Patient has a history of interstitial lung disease and normally requires 2-4 L of oxygen via nc; diagnosed with pneumonia secondary to COVID-19 virus.  Tx w/ steorids, zinc, advair, singular, remdesivir, abx, O2; weaned down to 2 L of oxygen via nasal cannula; dc'd to SNF.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Hypotension
Clinical narrative: HYPOTENSION
Age: 67.0
Sex: M
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: Covid vaccine was administered to patient past BUD date and therefore was not valid. Patient did not have any adverse event post vaccination.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: Covid vaccine was administered to patient past BUD date and therefore was not valid. Patient did not have any adverse event post vaccination.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Chronic respiratory failure, Respiratory failure
Clinical narrative: CHRONIC HYPOXEMIC RESPIRATORY FAILURE
Age: 11.0
Sex: M
Vaccine: COVID19-2, HPV9, MNQ, TDAP
Symptoms: Incorrect dose administered, No adverse event
Clinical narrative: Administration error.  Pt is 11.6 years old and received gray top Pfizer covid  bivalent for  12 and older rather than dose for 11 years old.  Pt stayed in clinic for 15 minutes post injection with no complications or adverse reaction.  Attempted phone call to parent for follow up, no answer.
Age: 36.0
Sex: F
Vaccine: COVID19-2
Symptoms: Expired product administered, No adverse event
Clinical narrative: Covid vaccine was administered to patient past BUD date and therefore was not valid. Patient did not have any adverse event post vaccination.
Age: 0.17
Sex: M
Vaccine: DTAPHEPBIP
Symptoms: Fatigue
Clinical narrative: Mother reported ( at the 4 month well visit) that infant was extremely tired following immunizations, he would wake up to feed then return to sleep for one week following immunization.  He did get PCV, HIB and rotavirus as well,  mother attributed reaction to Pertussis part of vaccine after researching vaccine side effects.   Mother is now reluctant to get further pertussis vaccines and would like to proceed with one vaccine at a time
Age: 29.0
Sex: F
Vaccine: COVID19-2
Symptoms: Expired product administered, No adverse event
Clinical narrative: Covid vaccine was administered to patient past BUD date and therefore was not valid. Patient did not have any adverse event post vaccination.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Cerebrovascular accident, Lacunar stroke, Symptom recurrence
Clinical narrative: ACUTE LACUNAR STROKE, UNSPECIFIED TYPE AND ARTERY ACUTE STROKE, UNSPECIFIED TYPE AND ARTERY 2/20/2023  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: Retrieving data. Wait a few seconds and try to cut or copy again.
Age: 0.75
Sex: M
Vaccine: MMR, PNC15, VARCEL
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: patient was given 12 month vaccinations mmr, varivax, vaxneuvance at 9 months instead of at 12 months  by mistake . patient was held for 20 min after the vaccinations were given. there was no adverse reactions to the vaccinations. the only issue was that they were given early for what is concidered the time frame to receive these vaccinations.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Obstructive sleep apnoea syndrome, Respiratory failure, Symptom recurrence
Clinical narrative: ADULT OBSTRUCTIVE SLEEP APNEA, SEVERE HYPOXEMIC RESPIRATORY FAILURE, UNSPECIFIED ACUITY 2/11/2023,  1/26/2023,  1/21/2023  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Age: 16.0
Sex: F
Vaccine: MNQ
Symptoms: Extra dose administered, No adverse event
Clinical narrative: No adverse reaction or side effects. Pt. was given a extra dose of mcv4 that was not needed since she had all ready received one in 10/19/2022.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Pulmonary embolism
Clinical narrative: ACUTE PULMONARY EMBOLISM
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure
Clinical narrative: ACUTE RESPIRATORY FAILURE
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Acute myocardial infarction, Angina pectoris, Angina unstable
Clinical narrative: UNSTABLE ANGINA ANGINA, UNSPECIFIED ACUTE NON ST ELEVATION MI
Age: 44.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Chemotherapy, Diarrhoea, Nasal congestion, Oropharyngeal pain
Clinical narrative: Patient with history of COVID-19 vaccination admitted to hospital with COVID-19 detected PCR. Provider d/c note: " 47 YO male with a past medical history of IgM gammopathy in July 2022 after evaluation of neuropathy, Waldenstrom macroglobulinemia and non-hodgkin's lymphoma that presents to the emergency department with complaints of fever as high as 101F at home with body aches, sore throat, diarrhea and nasal congestion. Patient reports having 3 episodes of diarrhea yesterday. Patient recently traveled after seeing his hematologist. Patient resides but has a summer home elsewhere. Patient reports last Chemo therapy of Bendamustine/Rituximab on 6/1/2023.  Patient started to recover as the fever was controlled. Patient was afebrile for > 24 hours and he was discharge in stable condition."
Age: 44.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Pain, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: Patient with history of COVID-19 vaccination admitted to hospital with COVID-19 detected PCR. Provider d/c note: " 47 YO male with a past medical history of IgM gammopathy in July 2022 after evaluation of neuropathy, Waldenstrom macroglobulinemia and non-hodgkin's lymphoma that presents to the emergency department with complaints of fever as high as 101F at home with body aches, sore throat, diarrhea and nasal congestion. Patient reports having 3 episodes of diarrhea yesterday. Patient recently traveled after seeing his hematologist. Patient resides but has a summer home elsewhere. Patient reports last Chemo therapy of Bendamustine/Rituximab on 6/1/2023.  Patient started to recover as the fever was controlled. Patient was afebrile for > 24 hours and he was discharge in stable condition."
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Acute myocardial infarction
Clinical narrative: ACUTE NON ST ELEVATION MI 5/1/2023 ACUTE NON ST ELEVATION MI
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Mobility decreased, Periarthritis, X-ray normal
Clinical narrative: In my left shoulder I can't move it or reach out. I am in pain and I've gone to physical therapy. They keep telling me its frozen shoulder. They did an x-ray and didn't see anything. My arm can't extend all the way out. Before getting the vaccine I was fine.
Age: 5.0
Sex: M
Vaccine: COVID19
Symptoms: Asthmatic crisis, Hypersensitivity
Clinical narrative: T78.40XA ALLERGIC REACTION, INIT 4/24/2022 ASTHMA, UNSPECIFIED W STATUS ASTHMATICUS
Age: 12.0
Sex: M
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: Vaccine was given 08/03/2023 prior to noticing that the use by date was 08/02/2023.
Age: 29.0
Sex: M
Vaccine: DT, PNC20
Symptoms: Faeces hard, Flatulence
Clinical narrative: Hard stools, severe intestinal gas
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Facial paresis, Hypersensitivity
Clinical narrative: PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE RIGHT FACIAL MUSCLE WEAKNESS ALLERGIC REACTION, INIT
Age: 28.0
Sex: F
Vaccine: TDAP
Symptoms: Exposure during pregnancy, Vaccination error
Clinical narrative: OB History - G3P2, currently pregnant at 30w4d. EDD 10/8/23.  Received TDAP vaccine 7/20/23 (this pregnancy) and again 8/3/23 in error as the 7/20/23 dose was not seen and patient did not say anything. Pharmacist contacted as well as the manufacturer of the vaccine GlaxoSmithCline. No known side effects or adverse outcomes to patient at this time.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Cardiac monitoring, Cerebrovascular accident, Computerised tomogram, Laboratory test
Clinical narrative: Stroke
Age: 1.33
Sex: F
Vaccine: DTAP, HIBV
Symptoms: Erythema, Induration, Rash vesicular, Skin lesion, Skin warm
Clinical narrative: red, warm, hard, wheel like rash with vesicular lesions , worsened after first onset for 24 hours then started to improved. treated with supportive care and close follow up
Age: 1.33
Sex: F
Vaccine: DTAP, HIBV
Symptoms: Urticaria
Clinical narrative: red, warm, hard, wheel like rash with vesicular lesions , worsened after first onset for 24 hours then started to improved. treated with supportive care and close follow up
Age: 10.0
Sex: F
Vaccine: HPV9
Symptoms: Dizziness, Headache, Nausea, Pain, Wrong product administered
Clinical narrative: Administered the wrong vaccine, was mistaken for a tdap vaccine  Patient has nausea, headaches, dizziness and body aches
Age: 11.0
Sex: M
Vaccine: MNQ, TDAP
Symptoms: Erythema, Pruritus, Swelling, Tenderness
Clinical narrative: RAISED RED BUMP, VERY TENDER AND ITCHY. MOM TREATED WITH BENADRYL AND TYLENOL
Age: 5.0
Sex: F
Vaccine: DTAPIPV, HEPA, HEPAB, MMRV
Symptoms: No adverse event, Wrong product administered
Clinical narrative: Client  recieved Twinrix by mistake No reported side effects  Unable to reach parent via phone
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Transient ischaemic attack
Clinical narrative: PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE TRANSIENT CEREBRAL ISCHEMIA
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Neuropathy peripheral, Symptom recurrence
Clinical narrative: PERIPHERAL NEUROPATHY 12/16/2022  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Sleep apnoea syndrome
Clinical narrative: SLEEP APNEA
Age: 3.0
Sex: M
Vaccine: COVID19
Symptoms: Cellulitis, Hypersensitivity
Clinical narrative: ALLERGIC REACTION, INIT 5/1/2023 CELLULITIS
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Chronic respiratory failure, Hypoxia, Respiratory failure
Clinical narrative: PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE CHRONIC HYPOXEMIC RESPIRATORY FAILURE RESPIRATORY FAILURE, UNSPECIFIED ACUITY HYPOXIA
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Deep vein thrombosis
Clinical narrative: ACUTE DVT OF RIGHT FEMORAL VEIN
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Acute myocardial infarction
Clinical narrative: ACUTE NON ST ELEVATION MI
Age: 11.0
Sex: M
Vaccine: MNQ, TDAP
Symptoms: Injection site bruising, Injection site erythema, Injection site indentation, Injection site induration, Injection site swelling
Clinical narrative: Mother stated that her son was having a reaction to the vaccines administered on Tuesday 08-01-2023. She stated that his arm was red, bruised, swollen around injection site and was hard around the " hole ". He also had a couple of bubbles at injection sites. Patient was also feverish. Mother stated that she administered ibuprofen and was putting cool compresses around sites. I suggested to her that she could take her son to his primary care provider if she felt that it was necessary and for further treatment. Educated regarding VIS forms that she received at time of vaccine administration and she verified that she did read them and noted the side effects listed.
Age: 11.0
Sex: M
Vaccine: MNQ, TDAP
Symptoms: Pyrexia
Clinical narrative: Mother stated that her son was having a reaction to the vaccines administered on Tuesday 08-01-2023. She stated that his arm was red, bruised, swollen around injection site and was hard around the " hole ". He also had a couple of bubbles at injection sites. Patient was also feverish. Mother stated that she administered ibuprofen and was putting cool compresses around sites. I suggested to her that she could take her son to his primary care provider if she felt that it was necessary and for further treatment. Educated regarding VIS forms that she received at time of vaccine administration and she verified that she did read them and noted the side effects listed.
Age: 10.0
Sex: M
Vaccine: COVID19-2
Symptoms: Eye swelling, Pruritus, Urticaria
Clinical narrative: According to mother had itching about 30-40 minutes after admin with hives on trunk and limbs, eye swelling. Patient stable with improvement of symptoms today, no concern for anaphylaxis or emergency services during follow up  visit.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Myelitis transverse
Clinical narrative: TRANSVERSE MYELITIS
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Pulmonary embolism
Clinical narrative: ACUTE PULMONARY EMBOLISM
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Acute myocardial infarction
Clinical narrative: PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE ACUTE NON ST ELEVATION MI
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, Symptom recurrence
Clinical narrative: ACUTE HYPOXEMIC RESPIRATORY FAILURE 1/8/2023  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Age: 29.0
Sex: M
Vaccine: COVID19-2, TDAP
Symptoms: Electrocardiogram abnormal, Loss of consciousness, Pallor, Sinus bradycardia, Syncope
Clinical narrative: Vasovagal syncope after receiving Tdap and COVID booster vaccines.  While receiving his vaccine, patient was noted to become pale, slumped forward in his chair, and lose consciousness for about 45 seconds (this was reported by medical assistant administering vaccine).  A CODE BLUE was called, I responded to find patient pale but awake and alert.  Pulse slightly bradycardic, cardiovascular exam otherwise normal.  Patient was transferred to a reclined position and repeated vitals were obtained, which were stable.  He declined chest pain or other symptoms.  He began to improve symptomatically, was provided with a juice box.  EKG obtained out of an abundance of caution, showed sinus bradycardia without other significant findings.  Patient improved symptomatically completely.  This is consistent with an episode of vasovagal syncope related to vaccine.
Age: 66.0
Sex: F
Vaccine: VARZOS
Symptoms: Erythema, Injection site rash, Rash, Rash erythematous
Clinical narrative: Pt showed me a red rash on her upper right arm starting around the injection site. It ended near her elbow. She stated that it was painful. She also had a small amount of redness on the right side of her neck. She said it started to develop in the evening on the same day she received her immunization. She has not taken anything prescription or OTC. I called her PCP's office, and spoke to nurse to let them know. Nurse said she would inform the PCP and contact the pt.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Hypotension, Symptom recurrence
Clinical narrative: PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE HYPOTENSION 7/29/2022,  3/9/2023,  3/21/2023  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Age: 65.0
Sex: F
Vaccine: VARZOS
Symptoms: Asthenia, Diarrhoea, Mobility decreased, Pain, Pain in extremity
Clinical narrative: Other than a sore arm that evening(Monday), on Tuesday I did not leave my bed except to run to the bathroom for diarrhea and I had a fever and did not have the strength to even get up to feed myself. on Wednesday and Thursday I still diarrhea. 3 days of body aches and pains as well.
Age: 65.0
Sex: F
Vaccine: VARZOS
Symptoms: Pyrexia
Clinical narrative: Other than a sore arm that evening(Monday), on Tuesday I did not leave my bed except to run to the bathroom for diarrhea and I had a fever and did not have the strength to even get up to feed myself. on Wednesday and Thursday I still diarrhea. 3 days of body aches and pains as well.
Age: 64.0
Sex: F
Vaccine: COVID19-2
Symptoms: Feeling abnormal, Hypoaesthesia, Paraesthesia
Clinical narrative: patient described that after leaving pharmacy approximately 15 minutes later she experienced tingling  and numbness in all her finger tips and felt very strange. She was in another retail establishment and stated she just stood quiet for 10 minutes or so and then felt better so went on her way.  No treatment was sought out and no other symptoms occurred.
Age: 43.0
Sex: M
Vaccine: TDAP, TYP
Symptoms: Localised oedema, Magnetic resonance imaging abnormal, Pain, Pain in extremity, Sleep disorder
Clinical narrative: Pt reported very sore L arm a few days after vaccine  administration. He notes the pain was constant since vax admin.  Rates pain as between 3 - 7 out of 10 (depending on movement and time of day).  Can sleep on left side. Pain worse when reaching across his body and with abduction of arm (particularly if lifting something).
Age: 43.0
Sex: M
Vaccine: TDAP, TYP
Symptoms: Tendon disorder, Ultrasound scan normal
Clinical narrative: Pt reported very sore L arm a few days after vaccine  administration. He notes the pain was constant since vax admin.  Rates pain as between 3 - 7 out of 10 (depending on movement and time of day).  Can sleep on left side. Pain worse when reaching across his body and with abduction of arm (particularly if lifting something).
Age: 12.0
Sex: M
Vaccine: COVID19-2, HPV9, MNQ, TDAP
Symptoms: Chest discomfort, Dyspnoea
Clinical narrative: Patient complained of not being being able to catch his breath. Chest was feeling tight. No complaints of feeling dizzy. 10:35 am his vitals 02 sat were 99 Heart rate was 85 Blood Pressure 100/65 respiration 24 and patient stated he felt better. NO signs or symptoms of respiratory distress noted. Vital signs prior to release at 10:50 am were 02 sat 99%. Heart rate 82.  Blood pressure 108/66. Respiratory rate was 20. Patient stated he continued to feel fine. No respiratory distress noted. Released to leave at 10:53 with guardian/aunt.
Age: 41.0
Sex: M
Vaccine: HEP, HEPA, HPV9, MMRV, TDAP, VARCEL
Symptoms: Wrong product administered
Clinical narrative: Client received MMRV instead of just MMR.  Client also received Varicella.  Client is older then 12 years old and client received Varicella vaccine the same day.  Dr. for Dept. of Health made aware and recommendation received to give client MMR vaccine & Varicella vaccine # 2 at his return appointment on 8/28/23.  No report of any adverse side effects from client.
Age: 62.0
Sex: M
Vaccine: VARZOS
Symptoms: Rash, Urticaria
Clinical narrative: Pt had hives and rash bilateral arms, bilateral legs, back, neck, torso, not on abdomen area.  Symptoms resolved on their own.  Started having symptoms about 2 hours after receiving the shot
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Respiratory failure
Clinical narrative: HYPERCAPNIC RESPIRATORY FAILURE, UNSPECIFIED ACUITY
Age: 83.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure
Clinical narrative: ACUTE RESPIRATORY FAILURE
Age: 0.5
Sex: M
Vaccine: DTAPHEPBIP, DTAPIPVHIB, PNC13
Symptoms: No adverse event, Wrong product administered
Clinical narrative: On the day of the vaccination, we mistakenly gave Pentacel vaccine instead of an ActHib and he was also administered a Pediarix.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Epilepsy, Symptom recurrence
Clinical narrative: EPILEPSY, UNSPECIFIED 10/24/2022  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Discomfort, Fatigue, Injection site erythema, Injection site inflammation, Nasopharyngitis
Clinical narrative: My daughter came to for the holidays in December 2019. She was sick when she arrived. I became ill with the same symptoms three days later. We had all the symptoms of COVID and I was on an study for which I sent three blood samples. I believe I was an early adopter of COVID, and have since had FIVE vaccinations. EACH TIME I FELT LIKE I HAD COVID. I feel like I have COVID now. I just took a COVID test. It was negative, but I like science, especially self-science. BUT TELL THAT NEGATIVE RESULT TO MY  BODY because I feel like I have the start of a cold and tremendous fatigue (I am normally very energetic and rarely take naps), and I feel like I have a fever. But I also live in  City, so.... Anyway, I am just reporting in because I think others need to know that reactions to the vaccine might mimic the disease and they could be in for a few days of discomfort as well as redness (inflammation) at the site of the injection. Thank you. May whomever reads this stay well and hearty and hale.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, SARS-CoV-2 test negative
Clinical narrative: My daughter came to for the holidays in December 2019. She was sick when she arrived. I became ill with the same symptoms three days later. We had all the symptoms of COVID and I was on an study for which I sent three blood samples. I believe I was an early adopter of COVID, and have since had FIVE vaccinations. EACH TIME I FELT LIKE I HAD COVID. I feel like I have COVID now. I just took a COVID test. It was negative, but I like science, especially self-science. BUT TELL THAT NEGATIVE RESULT TO MY  BODY because I feel like I have the start of a cold and tremendous fatigue (I am normally very energetic and rarely take naps), and I feel like I have a fever. But I also live in  City, so.... Anyway, I am just reporting in because I think others need to know that reactions to the vaccine might mimic the disease and they could be in for a few days of discomfort as well as redness (inflammation) at the site of the injection. Thank you. May whomever reads this stay well and hearty and hale.
Age: 54.0
Sex: F
Vaccine: VARZOS
Symptoms: Myalgia, Rash, Urticaria
Clinical narrative: Patient returned to pharmacy 8/3 and reported muscle pain occured day after receiving first dose shingrix, then started to break out in hive on right side of neck. Rash still appears on skin 8/3 that is now on back of scalp as well. Patient is going to urgent care to be assessed.
Age: 4.0
Sex: F
Vaccine: VARCEL
Symptoms: Blister, Erythema, Feeling hot, Immunisation reaction, Induration
Clinical narrative: Varicella vaccine given on 8/1/23 in left upper arm. Came in clinic today with suspected reaction to vaccine.  There was a 6cm erythema. There was induration, warmth and a vesicular area in the center of reaction noted.
Age: 5.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered, No adverse event
Clinical narrative: the member was 5 years old at the time of injection and was given the blue cap Moderna instead of the pink cap. The patient had two monovalent Moderna and was supposed to be given 0.20ML Moderna as the third dose but received the 0.25 dose which is designed for 1 previous monovalent dose.
Age: 0.67
Sex: M
Vaccine: COVID19-2
Symptoms: Incorrect product formulation administered
Clinical narrative: Pt given 6m - 4 yr bivalent booster dose for both doses in a primary series instead of the the 6m+ (Blue cap) formulation.   After initial error message in agency, provider called agency to inquire about error message, and was told it was related to a delay in updating the new approval of the bivalent formulation for use as a primary series, and that it would auto correct.  Second dose given at appropriate interval and error not caught until vaccine provider call mentioned it.
Age: 11.0
Sex: F
Vaccine: COVID19-2, COVID19-2
Symptoms: Extra dose administered
Clinical narrative: This child was adversely given two covid vaccinations. The incorrect vaccine was Pfizer Bivalent GK0928.
Age: 17.0
Sex: F
Vaccine: MENB
Symptoms: Injection site pain
Clinical narrative: Mother of patient called the office the day after receiving the vaccine stating that the patient had severe pain in her arm at the site of injection and was worried that she had developed SIRVA. It was her second dose of the vaccine and mom said she didn't have pain like that with her first dose. We asked mom to send us a picture of her arm so we could try to identify if the vaccine was injected too high in the upper arm and she has yet to send us anything.
Age: 26.0
Sex: M
Vaccine: COVID19
Symptoms: Blood test normal, Paraesthesia, Pruritus, Sensory disturbance
Clinical narrative: - Itching/prickling/tingling sensation started in lower left leg and quickly spread to both legs, arms, chest, and back - Strange sensation on left side of the face?feels like something is lightly brushing against it when nothing is  - Symptoms eased up ~60% in the first month but have never fully gone away. Has been nearly 2 years.
Age: 91.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site warmth
Clinical narrative: Red area noted around vaccination sight along with skin warm to touch.  Noted 48 hours after vaccination.  This vaccination was given at a clinic visit not within the nursing home facility.
Age: 26.0
Sex: F
Vaccine: HPV9, TDAP
Symptoms: Rash, Rash pruritic
Clinical narrative: Gardasil 9 and Adacel administered on 7/31/23. Presented to ED on 8/3/23 with pruritic rash on abdomen, chest, arms, and back that started previous day. Patient was administered epinephrine, prednisone, and cetirizine. Follow an observation period, patient reported improvement with less pruritic rash.
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Intracardiac thrombus
Clinical narrative: MURAL THROMBUS OF HEART POST ACUTE MI
Age: 0.5
Sex: M
Vaccine: DTPPVHBHPB, HIBV, DTPPVHBHPB, HIBV, RV5, DTPPVHBHPB, HIBV
Symptoms: Extra dose administered, No adverse event
Clinical narrative: Patient was given a dose of Vaxelis and a dose of ActHIB on the same day which is equivalent to a double dose of HIB. Doctor informed, parents informed, state immunization system informed, and an internal event reporting system completed. Manufacturer of vaccinations was notified. Per CDC it is not harmful to get a double dose of HIB.